$19.62
+0.2
(+1.03%)▲
2.09%
Downside
Day's Volatility :2.64%
Upside
0.56%
2.6%
Downside
52 Weeks Volatility :29.25%
Upside
27.36%
Period | Huntsman Corporation | Sector (Materials) | Index (Russel 2000) |
---|---|---|---|
3 Months | -6.57% | 2.2% | 0.0% |
6 Months | -22.88% | 2.4% | 0.0% |
1 Year | -21.33% | 15.8% | 0.0% |
3 Years | -40.4% | 5.8% | -24.1% |
Market Capitalization | 3.4B |
Book Value | $18.08 |
Dividend Share | 0.988 |
Dividend Yield | 5.15% |
Earnings Per Share (EPS) | -0.6 |
PEG Ratio | 1.79 |
Wall Street Target Price | 23.643 |
Profit Margin | -1.99% |
Operating Margin TTM | 3.18% |
Return On Assets TTM | 0.33% |
Return On Equity TTM | -1.34% |
Revenue TTM | 6.0B |
Revenue Per Share TTM | 34.79 |
Quarterly Revenue Growth YOY | 2.3% |
Gross Profit TTM | 1.5B |
EBITDA | 313.0M |
Diluted Eps TTM | -0.6 |
Quarterly Earnings Growth YOY | 0.21 |
EPS Estimate Current Year | 0.09 |
EPS Estimate Next Year | 0.9 |
EPS Estimate Current Quarter | 0.09 |
EPS Estimate Next Quarter | 0.04 |
What analysts predicted
Upside of 20.5%
FY18 | Y/Y Change | |
---|---|---|
Revenue | 9.4B | ↑ 12.22% |
Net Income | 337.0M | ↓ 47.01% |
Net Profit Margin | 3.59% | ↓ 4.02% |
FY19 | Y/Y Change | |
---|---|---|
Revenue | 6.8B | ↓ 27.53% |
Net Income | 429.0M | ↑ 27.3% |
Net Profit Margin | 6.31% | ↑ 2.72% |
FY20 | Y/Y Change | |
---|---|---|
Revenue | 6.0B | ↓ 11.46% |
Net Income | 291.0M | ↓ 32.17% |
Net Profit Margin | 4.84% | ↓ 1.47% |
FY21 | Y/Y Change | |
---|---|---|
Revenue | 8.5B | ↑ 40.46% |
Net Income | 1.0B | ↑ 259.11% |
Net Profit Margin | 12.36% | ↑ 7.52% |
FY22 | Y/Y Change | |
---|---|---|
Revenue | 8.0B | ↓ 5.09% |
Net Income | 460.0M | ↓ 55.98% |
Net Profit Margin | 5.73% | ↓ 6.63% |
FY23 | Y/Y Change | |
---|---|---|
Revenue | 6.1B | ↓ 23.83% |
Net Income | 101.0M | ↓ 78.04% |
Net Profit Margin | 1.65% | ↓ 4.08% |
Q2 FY23 | Q/Q Change | |
---|---|---|
Revenue | 1.6B | ↓ 0.62% |
Net Income | 19.0M | ↓ 56.82% |
Net Profit Margin | 1.19% | ↓ 1.55% |
Q3 FY23 | Q/Q Change | |
---|---|---|
Revenue | 1.5B | ↓ 5.64% |
Net Income | 69.0M | ↑ 263.16% |
Net Profit Margin | 4.58% | ↑ 3.39% |
Q4 FY23 | Q/Q Change | |
---|---|---|
Revenue | 1.4B | ↓ 6.84% |
Net Income | -71.0M | ↓ 202.9% |
Net Profit Margin | -5.06% | ↓ 9.64% |
Q1 FY24 | Q/Q Change | |
---|---|---|
Revenue | 1.5B | ↑ 4.78% |
Net Income | -37.0M | ↓ 47.89% |
Net Profit Margin | -2.52% | ↑ 2.54% |
Q2 FY24 | Q/Q Change | |
---|---|---|
Revenue | 1.6B | ↑ 7.07% |
Net Income | 22.0M | ↓ 159.46% |
Net Profit Margin | 1.4% | ↑ 3.92% |
Q3 FY24 | Q/Q Change | |
---|---|---|
Revenue | 1.5B | ↓ 2.16% |
Net Income | -33.0M | ↓ 250.0% |
Net Profit Margin | -2.14% | ↓ 3.54% |
FY18 | Y/Y Change | |
---|---|---|
Total Assets | 8.0B | ↓ 22.36% |
Total Liabilities | 5.2B | ↓ 24.28% |
FY19 | Y/Y Change | |
---|---|---|
Total Assets | 8.3B | ↑ 4.61% |
Total Liabilities | 5.5B | ↑ 5.61% |
FY20 | Y/Y Change | |
---|---|---|
Total Assets | 8.7B | ↑ 4.72% |
Total Liabilities | 5.0B | ↓ 8.3% |
FY21 | Y/Y Change | |
---|---|---|
Total Assets | 9.4B | ↑ 7.79% |
Total Liabilities | 4.8B | ↓ 4.11% |
FY22 | Y/Y Change | |
---|---|---|
Total Assets | 8.2B | ↓ 12.48% |
Total Liabilities | 4.4B | ↓ 9.37% |
FY23 | Y/Y Change | |
---|---|---|
Total Assets | 7.2B | ↓ 11.82% |
Total Liabilities | 3.8B | ↓ 13.93% |
Q2 FY23 | Q/Q Change | |
---|---|---|
Total Assets | 7.6B | ↓ 2.71% |
Total Liabilities | 3.7B | ↓ 1.75% |
Q3 FY23 | Q/Q Change | |
---|---|---|
Total Assets | 7.4B | ↓ 2.44% |
Total Liabilities | 3.7B | ↑ 0.22% |
Q4 FY23 | Q/Q Change | |
---|---|---|
Total Assets | 7.2B | ↓ 1.64% |
Total Liabilities | 3.8B | ↑ 1.48% |
Q1 FY24 | Q/Q Change | |
---|---|---|
Total Assets | 7.6B | ↑ 4.47% |
Total Liabilities | 4.2B | ↑ 10.82% |
Q2 FY24 | Q/Q Change | |
---|---|---|
Total Assets | 7.3B | ↓ 3.37% |
Total Liabilities | 4.0B | ↓ 4.72% |
Q3 FY24 | Q/Q Change | |
---|---|---|
Total Assets | 7.3B | ↑ 0.23% |
Total Liabilities | 4.0B | ↑ 0.2% |
FY18 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 1.2B | ↓ 0.98% |
Investing Cash Flow | -973.0M | ↑ 129.48% |
Financing Cash Flow | -424.0M | ↓ 18.3% |
FY19 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 897.0M | ↓ 25.68% |
Investing Cash Flow | -260.0M | ↓ 73.28% |
Financing Cash Flow | -450.0M | ↑ 6.13% |
FY20 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 253.0M | ↓ 71.79% |
Investing Cash Flow | 1.5B | ↓ 662.69% |
Financing Cash Flow | -655.0M | ↑ 45.56% |
FY21 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 952.0M | ↑ 276.28% |
Investing Cash Flow | -524.0M | ↓ 135.82% |
Financing Cash Flow | -977.0M | ↑ 49.16% |
FY22 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 914.0M | ↓ 3.99% |
Investing Cash Flow | -279.0M | ↓ 46.76% |
Financing Cash Flow | -994.0M | ↑ 1.74% |
Q2 FY23 | Q/Q Change | |
---|---|---|
Operating Cash Flow | 40.0M | ↓ 125.97% |
Investing Cash Flow | -49.0M | ↓ 110.02% |
Financing Cash Flow | -85.0M | ↓ 77.57% |
Q3 FY23 | Q/Q Change | |
---|---|---|
Operating Cash Flow | 163.0M | ↑ 307.5% |
Investing Cash Flow | 391.0M | ↓ 897.96% |
Financing Cash Flow | -117.0M | ↑ 37.65% |
Sell
Neutral
Buy
Huntsman Corporation is currently in a neutral trading position according to technical analysis indicators.
Company Name | 1 Month | 6 Month | 1 Year | 3 Years | 5 Years |
---|---|---|---|---|---|
Huntsman Corporation | -14.47% | -22.88% | -21.33% | -40.4% | -15.61% |
Dow Inc. | -13.94% | -22.2% | -12.82% | -23.78% | -17.32% |
Celanese Corporation | -42.91% | -51.05% | -43.06% | -54.82% | -39.9% |
Olin Corp. | -8.17% | -22.8% | -10.92% | -29.45% | 149.23% |
Company Name | P/E Ratio | P/B Ratio | PEG Ratio | EPS | ROE | ROA | Div Yield | BVPS |
---|---|---|---|---|---|---|---|---|
Huntsman Corporation | 46.54 | NA | 1.79 | 0.09 | -0.01 | 0.0 | 0.05 | 18.08 |
Dow Inc. | 29.29 | 29.29 | 0.59 | 2.07 | 0.06 | 0.02 | 0.06 | 26.16 |
Celanese Corporation | 7.47 | 7.47 | 4.42 | 8.15 | 0.15 | 0.03 | 0.04 | 66.57 |
Olin Corp. | 32.39 | 32.39 | 1.82 | 1.02 | 0.06 | 0.03 | 0.02 | 17.64 |
Company Name | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin |
---|---|---|---|---|---|
Huntsman Corporation | Hold | $3.4B | -15.61% | 46.54 | -1.99% |
Dow Inc. | Hold | $30.8B | -17.32% | 29.29 | 2.46% |
Celanese Corporation | Buy | $8.2B | -39.9% | 7.47 | 10.4% |
Olin Corp. | Buy | $4.8B | 149.23% | 32.39 | 2.33% |
Insights on Huntsman Corporation
Revenue is down for the last 2 quarters, 1.57B → 1.54B (in $), with an average decrease of 2.2% per quarter
Netprofit is down for the last 2 quarters, 22.0M → -33.0M (in $), with an average decrease of 250.0% per quarter
In the last 1 year, Huntsman Corporation has experienced a drawdown of -21.3%, however Olin Corp. resisted the overall trend and outperformed by 10.4%
In the last 3 years, Huntsman Corporation has experienced a drawdown of -40.4%, however Dow Inc. resisted the overall trend and outperformed by 11.0%
Vanguard Group Inc
BlackRock Inc
Dimensional Fund Advisors, Inc.
Allspring Global Investments Holdings, LLC
Charles Schwab Investment Management Inc
Morgan Stanley - Brokerage Accounts
In the quarter ending March,2024. Huntsman Corporation has declared dividend of $0.25
Read Morehuntsman corporation is a publicly traded global manufacturer and marketer of differentiated chemicals with 2014 revenues of approximately $13 billion including the acquisition of rockwood’s performance additives and tio2 businesses. our chemical products number in the thousands and are sold worldwide to manufacturers serving a broad and diverse range of consumer and industrial end markets. we operate more than 100 manufacturing and r&d facilities in more than 30 countries and employ approximately 16,000 associates within our 5 distinct business divisions. for more information about huntsman, please visit the company's website at www.huntsman.com.
Organization | Huntsman Corporation |
Employees | 6000 |
CEO | Mr. Peter R. Huntsman |
Industry | Process Industries |
Cleanspark Inc
$19.62
+1.03%
Vaneck Vectors Fallen Angel Hiyld Bd Etf
$19.62
+1.03%
Borgwarner Inc.
$19.62
+1.03%
Central Garden & Pet Co A Shares
$19.62
+1.03%
Esab Corp
$19.62
+1.03%
Sasol Ltd.
$19.62
+1.03%
Ishares Msci Eafe Min Vol Factor Etf
$19.62
+1.03%
Vanguard Ultra Short Bond Et
$19.62
+1.03%
Hutchison China Meditech Limited
$19.62
+1.03%